PriceTargets.com logo

NASDAQ:AQB - AquaBounty Technologies Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $5.25
  • Forecasted Upside: 254.73 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$1.48 As of 08/16/2022 10:31 AM ET
+0 (0.00%)

This chart shows the closing price for AQB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New AquaBounty Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AQB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AQB

Analyst Price Target is $5.25
▲ +254.73% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for AquaBounty Technologies in the last 3 months. The average price target is $5.25, with a high forecast of $6.00 and a low forecast of $4.50. The average price target represents a 254.73% upside from the last price of $1.48.

This chart shows the closing price for AQB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 investment analysts is to buy stock in AquaBounty Technologies. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/21/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/22/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/20/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/18/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/16/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/17/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/16/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/15/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/9/2021HC WainwrightUpgradeNeutral ➝ Buy$4.50Low
10/8/2021Roth CapitalInitiated CoverageBuy$6.00Medium
7/30/2021Lake Street CapitalReiterated RatingBuy$15.00Low
6/30/2021OppenheimerInitiated CoverageOutperform$7.00Medium
3/16/2021HC WainwrightReiterated RatingBuy ➝ NeutralHigh
3/10/2021HC WainwrightDowngradeBuy ➝ NeutralLow
12/11/2020Lake Street CapitalBoost Price Target$5.00 ➝ $9.00Low
11/4/2020National SecuritiesReiterated RatingBuy$5.00Low
8/24/2020National SecuritiesReiterated RatingBuy$5.00High
6/12/2020HC WainwrightReiterated RatingBuy$3.50High
5/22/2020HC WainwrightReiterated RatingBuy$3.50N/A
5/21/2020National SecuritiesReiterated RatingBuy$5.00High
5/7/2020HC WainwrightReiterated RatingBuy$3.50High
5/6/2020National SecuritiesReiterated RatingBuy$5.00High
3/26/2020HC WainwrightLower Price TargetBuy$3.75 ➝ $3.50Low
3/12/2020Lake Street CapitalInitiated CoverageBuy$5.00High
3/11/2020National SecuritiesReiterated RatingBuy$5.00High
1/13/2020National SecuritiesUpgradeNeutral ➝ BuyMedium
9/20/2019National SecuritiesDowngradeBuy ➝ NeutralHigh
8/7/2019National SecuritiesReiterated RatingBuy ➝ Buy$5.00 ➝ $5.00Low
7/11/2019HC WainwrightSet Price TargetBuy$4.00High
6/10/2019National SecuritiesReiterated RatingBuy ➝ Buy$5.00 ➝ $5.00Low
5/10/2019HC WainwrightReiterated RatingBuy$3.75High
5/6/2019National SecuritiesReiterated RatingBuy ➝ Buy$5.00 ➝ $5.00Low
3/28/2019HC WainwrightSet Price TargetBuy$4.00Medium
3/20/2019National SecuritiesLower Price TargetBuy ➝ Buy$6.50 ➝ $5.50Low
3/6/2019National SecuritiesInitiated CoverageBuy ➝ Buy$6.50 ➝ $6.50High
12/27/2018HC WainwrightSet Price TargetBuy$4.00High
11/28/2018HC WainwrightSet Price TargetBuy$4.00Low
11/16/2018HC WainwrightSet Price TargetBuy$4.00Medium
9/17/2018HC WainwrightSet Price TargetBuy$4.00High
8/8/2018HC WainwrightReiterated RatingBuy$4.00High
6/28/2018HC WainwrightInitiated CoverageBuy$3.75Low
(Data available from 8/16/2017 forward)

News Sentiment Rating

0.61 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
1/18/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/17/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/19/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/18/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/18/2022
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/17/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/17/2022
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
8/16/2022

Current Sentiment

  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

AquaBounty Technologies logo
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
Read More

Today's Range

Now: $1.48
Low: $1.44
High: $1.48

50 Day Range

MA: $1.58
Low: $1.43
High: $1.78

52 Week Range

Now: $1.48
Low: $1.13
High: $4.75

Volume

653 shs

Average Volume

435,780 shs

Market Capitalization

$105.24 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95

Frequently Asked Questions

What sell-side analysts currently cover shares of AquaBounty Technologies?

The following sell-side analysts have issued stock ratings on AquaBounty Technologies in the last year: HC Wainwright, and Roth Capital.
View the latest analyst ratings for AQB.

What is the current price target for AquaBounty Technologies?

2 Wall Street analysts have set twelve-month price targets for AquaBounty Technologies in the last year. Their average twelve-month price target is $5.25, suggesting a possible upside of 254.7%. Roth Capital has the highest price target set, predicting AQB will reach $6.00 in the next twelve months. HC Wainwright has the lowest price target set, forecasting a price of $4.50 for AquaBounty Technologies in the next year.
View the latest price targets for AQB.

What is the current consensus analyst rating for AquaBounty Technologies?

AquaBounty Technologies currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AQB will outperform the market and that investors should add to their positions of AquaBounty Technologies.
View the latest ratings for AQB.

What other companies compete with AquaBounty Technologies?

Other companies that are similar to AquaBounty Technologies include Endo International, Rezolute, BriaCell Therapeutics, Summit Therapeutics and Compugen. Learn More about companies similar to AquaBounty Technologies.

How do I contact AquaBounty Technologies' investor relations team?

AquaBounty Technologies' physical mailing address is 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754. The company's listed phone number is (978) 648-6000 and its investor relations email address is [email protected] The official website for AquaBounty Technologies is www.aquabounty.com. Learn More about contacing AquaBounty Technologies investor relations.